Repro Med Systems Inc (KRMD) Stock Forecast & Price Target
Repro Med Systems Inc · NASDAQ
$4.08+0.25 (+6.53%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Repro Med Systems Inc, 3 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $6.00 to $8.00, so the covering firms are broadly aligned. The average target of $7.33 sits 80% above the current $4.08. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.01 next quarter toward $0.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold125%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Repro Med Systems Inc.
As of Jul, 3 of 4 firms rate KRMD a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
KRMD EPS & revenue forecast
EPS · NEXT QUARTER
$0.01
Range $0.00 – $0.01 · 2 analysts
Next period, 2 analysts expect Repro Med Systems Inc to earn $0.01 a share (range $0.00 – $0.01), versus $0.00 a year earlier. Full-year consensus is $0.02, growing to $0.08 the year after.
REVENUE · NEXT QUARTER
$12.3M
Range $12.0M – $12.6M · 2 analysts · +18% YoY
Revenue is expected to reach $12.3M (range $12.0M – $12.6M), +18.1% year-over-year. Full-year consensus is $48.7M, rising to $56.9M next year.
Top analysts covering Repro Med Systems Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KRMD.
#1
Chase Knickerbocker
Craig-Hallum · Rank #25
Buy
$6.00+47.1% to target
Overall win rate
58%
+ Follow
#2
Jason Bednar
Piper Sandler · Rank #303
Hold
$3.50-14.2% to target
Overall win rate
33%
+ Follow
#3
Frank Takkinen
Lake Street · Rank #327
Buy
$8.00+96.1% to target
Overall win rate
26%
+ Follow
#4
CR
Caitlin Roberts
Canaccord Genuity
Buy
$6.00+47.1% to target
Coverage
—
+ Follow
#5
WW
William Woods
B. Riley Securities
Buy
$8.00+96.1% to target
Coverage
—
+ Follow
KRMD stock forecast FAQ
What is KRMD's average 12-month price target?+
The 3 analysts with a live target average $7.33 for Repro Med Systems Inc over the next 12 months, ranging from a $8.00 high to a $6.00 low.
Is KRMD stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for KRMD?+
The Street-high target is $8.00 (B. Riley Securities), and the Street-low is $6.00 (Canaccord Genuity). The average of all 3 active targets is $7.33.
How many Wall Street analysts cover KRMD?+
4 analysts have an active rating on Repro Med Systems Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering KRMD?+
Among analysts who currently cover KRMD, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #25). Their current call is Buy with a $6.00 target.
What is Repro Med Systems Inc's projected EPS for next quarter?+
The consensus estimate is $0.01 per share (range $0.00 – $0.01) across 2 analysts. Full-year EPS is projected at $0.02, rising to $0.08 the following year.
How much revenue is Repro Med Systems Inc expected to report next quarter?+
Consensus revenue is $12.3M (range $12.0M – $12.6M). Full-year revenue is projected at $48.7M, growing to $56.9M next year.
Have analysts been upgrading or downgrading KRMD lately?+
As of Jul, 3 of 4 firms rate KRMD a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KRMD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
